Multicenter, Post-Marketing, Non-Interventional, Observational Study to Evaluate Persistence to Tocilizumab SC as Monotherapy or in Combination With cDMARD Treatment in RA Patients in Greece: the EMBRACE-SC Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms EMBRACE-SC
- Sponsors Roche
- 10 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 09 May 2017 Status changed from not yet recruiting to recruiting.
- 01 Aug 2016 Planned initiation date changed from 1 Jul 2016 to 1 Sep 2016.